Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,028.00
Bid: 11,850.00
Ask: 12,300.00
Change: 0.00 (0.00%)
Spread: 450.00 (3.797%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks rise as upbeat forecast from Volkswagen spurs rally in autos

Tue, 16th Mar 2021 09:23

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* European autos sector touches highest level since June
2018

* Zalando at 3-week peak, retail sector hits record high

* Volkswagen says cost cuts to boost margin, shares jump

* European stocks volatility gauge at February 2020 lows
(Adds analyst comments, updates prices throughout)

By Shreyashi Sanyal

March 16 (Reuters) - European stocks rose on Tuesday as an
upbeat forecast from German carmaker Volkswagen prompted a rally
in the automobiles sector, while investors awaited the U.S.
Federal Reserve's views on a recent pickup in inflation.

The pan-European STOXX 600 index rose 0.9%, inching
closer to a record peak set last year, while the regional autos
sector jumped 2.1% to its highest level since June 2018.

Leading gains among autos was Volkswagen AG
which jumped 6.7% after it said it was confident that cost cuts
will help improve profit margins in the coming years.

"There is something to do with more interest as global
investors are becoming more attracted to areas outside of
technology which would include sectors like autos, mining and
industrials," said Chris Bailey, European strategist at Raymond
James.

"Particularly for autos it is a combination of higher demand
as economies recover and also these are companies with proper
international businesses."

Zalando rose 5.0% after it forecast 2021 revenue
growth above market expectations following a strong start to the
year. Its shares touched a three-week high and lifted the wider
retail index.

A gauge of volatility in European stock markets
slipped to its lowest level in over one year.

Investors are focused on the Fed's two-day policy meeting,
which will end on Wednesday amid concerns that a potential spike
in inflation as economies recover could prompt the central bank
to tighten monetary policy sooner than expected.

Official data showed French final inflation rose largely in
line with estimates in February. Meanwhile, the ZEW economic
research institute said investor sentiment in Germany increased
by more than expected in March, buoying the outlook for a
broad-based recovery in Europe's largest economy.

While optimism about an economic recovery has pushed markets
to near-record highs, concerns remain about the pace of COVID-19
vaccination in Europe, with Sweden becoming the latest country
to pause AstraZeneca's vaccine after several countries
reported possible serious side-effects.

Deutsche Bank slashed 2021 economic growth forecasts for the
euro area by a percentage point, citing spillover of the ongoing
pandemic-linked activity curbs, but raised predictions for
Britain, the United States and India.

French telecoms operator Iliad SA jumped almost
4.5% after saying it aimed to turn a core profit for its Italian
business in the second half of this year.

German biotech firm Morphosys slumped
10.6????????% to the bottom of STOXX 600 after forecasting a
fall in 2021 revenue.
(Reporting by Sruthi Shankar and Devik Jain in Bengaluru
Editing by Arun Koyyur and Matthew Lewis)

More News
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.